Newsbenzinga
What's Going On With Celcuity Stock On Tuesday?
· Published
Article summary
Celcuity reported Phase 3 data showing gedatolisib improved progression-free survival in PIK3CA-mutated breast cancer.
An excerpt from the original article.Celcuity reported Phase 3 data showing gedatolisib improved progression-free survival in PIK3CA-mutated breast cancer.
An excerpt from the original article.
Comments —
Loading comments…